Shukla, A.; Cloutier, M.; Appiya Santharam, M.; Ramanathan, S.; Ilangumaran, S.
The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy. Int. J. Mol. Sci. 2021, 22, 1964.
https://doi.org/10.3390/ijms22041964
AMA Style
Shukla A, Cloutier M, Appiya Santharam M, Ramanathan S, Ilangumaran S.
The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy. International Journal of Molecular Sciences. 2021; 22(4):1964.
https://doi.org/10.3390/ijms22041964
Chicago/Turabian Style
Shukla, Akhil, Maryse Cloutier, Madanraj Appiya Santharam, Sheela Ramanathan, and Subburaj Ilangumaran.
2021. "The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy" International Journal of Molecular Sciences 22, no. 4: 1964.
https://doi.org/10.3390/ijms22041964
APA Style
Shukla, A., Cloutier, M., Appiya Santharam, M., Ramanathan, S., & Ilangumaran, S.
(2021). The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy. International Journal of Molecular Sciences, 22(4), 1964.
https://doi.org/10.3390/ijms22041964